Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Laborde

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancer Research|November 15, 1994
K252a, KT5720, KT5926, and U98017 support paclitaxel (taxol)-dependent cells and synergize with paclitaxelI Abraham, C L Wolf, K E Sampson, et al.
The Journal of Antibiotics|June 1, 1987
Arginomycin: production, isolation, characterization and structureA D Argoudelis, L Baczynskyj, M T Kuo, et al.
The Journal of Cardiovascular Surgery|July 1, 1992
A prospective comparison of ankle/brachial indices and color duplex imaging in surveillance of the in situ saphenous vein bypassA L Laborde, A Y Synn, M J Worsey, et al.
The Journal of Surgical Research|January 1, 1993
Endovascular canine anastomotic stentingM J Worsey, A L Laborde, B V Miller, et al.
Nature|April 12, 1990
Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist proteinD B Carter, M R Deibel, C J Dunn, et al.
The Journal of Biological Chemistry|August 25, 1990
Purification and characterization of interleukin 1 receptor level antagonist proteins from THP-1 cellsM J Bienkowski, T E Eessalu, A E Berger, et al.
Biochemistry|May 9, 2001
Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin actionJ E Bleasdale, D Ogg, B J Palazuk, et al.
Journal of Medicinal Chemistry|May 7, 1999
Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitorsE J Jacobsen, M A Mitchell, S K Hendges, et al.
British Journal of Cancer|August 27, 2009
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersO M Sinilnikova, A C Antoniou, J Simard, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Research|November 15, 1994
K252a, KT5720, KT5926, and U98017 support paclitaxel (taxol)-dependent cells and synergize with paclitaxelI Abraham, C L Wolf, K E Sampson, et al.
The Journal of Antibiotics|June 1, 1987
Arginomycin: production, isolation, characterization and structureA D Argoudelis, L Baczynskyj, M T Kuo, et al.
The Journal of Cardiovascular Surgery|July 1, 1992
A prospective comparison of ankle/brachial indices and color duplex imaging in surveillance of the in situ saphenous vein bypassA L Laborde, A Y Synn, M J Worsey, et al.
The Journal of Surgical Research|January 1, 1993
Endovascular canine anastomotic stentingM J Worsey, A L Laborde, B V Miller, et al.
Nature|April 12, 1990
Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist proteinD B Carter, M R Deibel, C J Dunn, et al.
The Journal of Biological Chemistry|August 25, 1990
Purification and characterization of interleukin 1 receptor level antagonist proteins from THP-1 cellsM J Bienkowski, T E Eessalu, A E Berger, et al.
Biochemistry|May 9, 2001
Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin actionJ E Bleasdale, D Ogg, B J Palazuk, et al.
Journal of Medicinal Chemistry|May 7, 1999
Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitorsE J Jacobsen, M A Mitchell, S K Hendges, et al.
British Journal of Cancer|August 27, 2009
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersO M Sinilnikova, A C Antoniou, J Simard, et al.
Pageof 2